Patents by Inventor Joe Craig Franklin

Joe Craig Franklin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200237726
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: November 26, 2019
    Publication date: July 30, 2020
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20180296534
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: June 19, 2018
    Publication date: October 18, 2018
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20150374671
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: September 4, 2015
    Publication date: December 31, 2015
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine pharmaceutical compositions
    Patent number: 8895756
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: November 25, 2014
    Assignee: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine pharmaceutical compositions
    Patent number: 8791270
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: July 29, 2014
    Assignee: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140148490
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: January 31, 2014
    Publication date: May 29, 2014
    Applicant: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20130338205
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: August 19, 2013
    Publication date: December 19, 2013
    Applicant: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine pharmaceutical compositions
    Patent number: 8609863
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: December 17, 2013
    Assignee: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine pharmaceutical compositions
    Patent number: 8461350
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: June 11, 2013
    Assignee: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine Pharmaceutical Compositions
    Publication number: 20130131131
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: December 19, 2012
    Publication date: May 23, 2013
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine Pharmaceutical Compositions
    Publication number: 20130123316
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: December 19, 2012
    Publication date: May 16, 2013
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine pharmaceutical compositions
    Patent number: 8436190
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: May 7, 2013
    Assignee: Cephalon, Inc.
    Inventors: Jason Edward Brittain, Joe Craig Franklin
  • Bendamustine Pharmaceutical Compositions
    Publication number: 20130041003
    Abstract: The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
    Type: Application
    Filed: October 18, 2012
    Publication date: February 14, 2013
    Inventors: Jason Edward Brittain, Joe Craig Franklin